The Eureka Moment Behind a Scientific Discovery
Leveraging AI, precision medicine and more, we create new, best-in-class ways to help people.
We're focused on finding better ways to bring the right medicines to patients – tailoring and personalizing our therapies and letting the patient voice and experience guide us. We’re investing in key areas and technologies such as precision medicine, data convergence, genetics and genomics and patient-focused drug development.
We believe that innovation in these areas — along with our unique mix of therapeutic modalities and advanced tools — will drive innovation within our pipeline, advance programs with a stronger probability of success, and increase our potential to deliver better solutions to patients.
We’re working to revolutionize R&D with artificial intelligence (AI), machine learning (ML) and an industry-leading data platform to help speed up the pace of discovery with the goal to bring medicines to patients faster.
With access to more than 1 million genomes, we’re leading one of the world’s largest genomics research efforts and working to develop and deliver new and more tailored medicines for the right patient at the right time.
From partnering with patients to advance drug development to diversifying our clinical trials to harnessing real-world data, our scientists use novel approaches that apply patient insights to deliver products and solutions for conditions with great unmet need.
We’re using advanced technologies to help accelerate medicines and leveraging deep understanding of disease mechanisms to target the right patient with the right medicine at the right time.
Through investments in breakthrough platform technologies, artificial intelligence (AI)/machine learning (ML) applications and drug delivery advances, we continue to grow our R&D toolbox — a mix of traditional and cutting-edge therapeutic modalities — to create the best compound for a specific target.
Explore our career opportunities.
You will be leaving your country’s AbbVie site and will be redirected to another country’s website. The AbbVie’s web site to where you will be redirected is exclusively designed for residents of particularly one or various countries, as announced in such web site. As a result, the website where you will be directed may contain pharmaceutical products information or other information that is not approved in other countries, regions or even in your country or territory of reference. If you live in a country other than those to which the site is directed, please contact your local AbbVie affiliate for the correct information on the products of your country of residence.